5-aminolaevulinic acid-photodynamic therapy for the treatment of cervical condylomata acuminata.
OBJECTIVE
To investigate the efficacy and safety of photodynamic therapy (PDT) with topical 5-aminolaevulinic acid (ALA) on cervical condylomata acuminata.


METHODS
Patients with cervical condylomata (n=30) were allocated into primary and recurrent group, and were given topical ALA under occlusive dressing for 3 hours followed by irradiation with semiconductor laser at a dose of 100 Jcm(-2) and a power of 100 mW. The treatment was repeated 7 days later if the lesion was not completely removed after the first treatment. Complete response rate and recurrence rate of wart lesions as well as rate of adverse reaction were analyzed.


RESULTS
The total complete response rate of PDT was 100% and the total recurrence rate was 5% after 3 months of follow-up. Recurrence rate of recurrent group was significantly lower than that of prior managements (100%, P<0.01). The side effects of PDT in patients mainly included mild burning and/or stinging restricted to the illuminated areas, and was significant lower than their own control (25% vs. 100%, P<0.05).


CONCLUSIONS
Compared with conventional therapies, topical application of ALA-PDT is a simple, effective, safe, well-tolerated, and low recurrence rate treatment for cervical condylomata acuminata.
Liu
Yong-Xin
YX
Department of Dermatology and Venereology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Zheng
He-Yi
HY
Liu
Xiu-Rong
XR
D000328:Adult; D000622:Aminolevulinic Acid / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010778:Photochemotherapy / Q000009:adverse effects; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012008:Recurrence; D002577:Uterine Cervical Diseases / Q000188:drug therapy*; D055815:Young Adult
D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid